Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads by Date
Must reads for theWeek ending June 21, 2015
Skin Cancer Projections Through 2030, A review of melanoma rates, mortality, costs, and prevention programs
Newborn Pulmonary Hypertension and Maternal Antidepressant Use, Large study shows modest increase in risk with some medications
Must reads for theWeek ending June 14, 2015
Infectious Skin Lesions Common Among Wrestlers, Public health review of outbreak following tournament
FDA Approves Eluxadoline for IBS, Twice daily mu-opioid receptor agonist
FDA Approves Rifaximin for IBS, Previously approved for travelers’ diarrhea
Must reads for theWeek ending June 7, 2015
Breast Density and Interval Cancer Rates , When additional imaging is warranted
Cancer Screening Recommendations from ACP, A quick look at the latest evidence-based guidelines
FDA Approves Stiolto Respimat for COPD , Combination of anticholinergic tiotropium and LABA olodaterol
Must reads for theWeek ending May 31, 2015
Novel Therapy for Treating Complicated UTIs, Results from the double-blind ASPECT-cUTI trial
Must reads for theWeek ending May 24, 2015
New Approach to Preventing Recurrent C. diff Infection , Colonization with nontoxigenic strain shows promise
Treating Overactive Bladder With Anticholinergics, Does therapy improve rates of urge incontinence?